Ameriprise
REGN icon

Ameriprise’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$152M Sell
287,699
-52,446
-15% -$27.7M 0.04% 427
2025
Q1
$216M Buy
340,145
+13,594
+4% +$8.62M 0.06% 313
2024
Q4
$232M Sell
326,551
-40,208
-11% -$28.6M 0.06% 302
2024
Q3
$386M Sell
366,759
-8,119
-2% -$8.54M 0.1% 214
2024
Q2
$395M Buy
374,878
+42,333
+13% +$44.6M 0.11% 202
2024
Q1
$320M Sell
332,545
-3,306
-1% -$3.18M 0.09% 239
2023
Q4
$295M Sell
335,851
-29,823
-8% -$26.2M 0.09% 239
2023
Q3
$301M Sell
365,674
-10,854
-3% -$8.93M 0.1% 210
2023
Q2
$271M Buy
376,528
+18,580
+5% +$13.3M 0.08% 244
2023
Q1
$294M Buy
357,948
+22,584
+7% +$18.6M 0.1% 223
2022
Q4
$242M Buy
335,364
+39,864
+13% +$28.8M 0.08% 249
2022
Q3
$204M Sell
295,500
-12,936
-4% -$8.92M 0.08% 271
2022
Q2
$182M Sell
308,436
-90,395
-23% -$53.4M 0.06% 311
2022
Q1
$278M Sell
398,831
-8,165
-2% -$5.7M 0.08% 255
2021
Q4
$257M Buy
406,996
+26,327
+7% +$16.6M 0.07% 290
2021
Q3
$230M Sell
380,669
-30,628
-7% -$18.5M 0.07% 287
2021
Q2
$230M Buy
411,297
+126,731
+45% +$70.8M 0.07% 292
2021
Q1
$135M Buy
284,566
+11,724
+4% +$5.56M 0.04% 400
2020
Q4
$132M Sell
272,842
-3,764
-1% -$1.82M 0.05% 401
2020
Q3
$155M Buy
276,606
+4,209
+2% +$2.36M 0.06% 306
2020
Q2
$170M Sell
272,397
-16,695
-6% -$10.4M 0.07% 266
2020
Q1
$141M Sell
289,092
-27,220
-9% -$13.3M 0.07% 259
2019
Q4
$119M Buy
316,312
+632
+0.2% +$237K 0.05% 350
2019
Q3
$87.6M Buy
315,680
+26,733
+9% +$7.42M 0.04% 449
2019
Q2
$90.4M Buy
288,947
+3,198
+1% +$1M 0.04% 454
2019
Q1
$117M Sell
285,749
-12,556
-4% -$5.16M 0.05% 351
2018
Q4
$111M Buy
298,305
+1,128
+0.4% +$421K 0.06% 341
2018
Q3
$120M Sell
297,177
-18,346
-6% -$7.41M 0.04% 395
2018
Q2
$109M Buy
315,523
+36,669
+13% +$12.6M 0.05% 387
2018
Q1
$96M Buy
278,854
+30,853
+12% +$10.6M 0.04% 395
2017
Q4
$93.2M Buy
248,001
+28,984
+13% +$10.9M 0.04% 394
2017
Q3
$97.9M Buy
219,017
+1,809
+0.8% +$809K 0.05% 374
2017
Q2
$107M Sell
217,208
-60,850
-22% -$29.9M 0.05% 335
2017
Q1
$108M Sell
278,058
-74,762
-21% -$29M 0.06% 329
2016
Q4
$130M Buy
352,820
+79,810
+29% +$29.3M 0.07% 285
2016
Q3
$110M Buy
273,010
+196,415
+256% +$79M 0.06% 317
2016
Q2
$26.7M Buy
76,595
+41,590
+119% +$14.5M 0.02% 756
2016
Q1
$12.6M Sell
35,005
-57,581
-62% -$20.8M 0.01% 1243
2015
Q4
$50.6M Sell
92,586
-84,515
-48% -$46.2M 0.03% 471
2015
Q3
$82.4M Buy
177,101
+94,614
+115% +$44M 0.05% 332
2015
Q2
$42.1M Buy
82,487
+1,420
+2% +$724K 0.02% 596
2015
Q1
$36.6M Buy
81,067
+47,103
+139% +$21.3M 0.02% 656
2014
Q4
$13.9M Buy
33,964
+1,735
+5% +$712K 0.01% 1224
2014
Q3
$11.6M Sell
32,229
-1,291
-4% -$465K 0.01% 1340
2014
Q2
$9.47M Buy
33,520
+584
+2% +$165K 0.01% 1583
2014
Q1
$9.89M Sell
32,936
-39,530
-55% -$11.9M 0.01% 1531
2013
Q4
$19.9M Sell
72,466
-111,360
-61% -$30.6M 0.01% 995
2013
Q3
$57.5M Buy
183,826
+45,813
+33% +$14.3M 0.04% 488
2013
Q2
$31M Buy
+138,013
New +$31M 0.02% 733